106 related articles for article (PubMed ID: 30987978)
1. Lulling the Cancer Cell into an Eternal Sleep.
Farrington CC; Narla G
Cancer Res; 2019 Apr; 79(8):1756-1757. PubMed ID: 30987978
[TBL] [Abstract][Full Text] [Related]
2. Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer.
Shinde A; Hardy SD; Kim D; Akhand SS; Jolly MK; Wang WH; Anderson JC; Khodadadi RB; Brown WS; George JT; Liu S; Wan J; Levine H; Willey CD; Krusemark CJ; Geahlen RL; Wendt MK
Cancer Res; 2019 Apr; 79(8):1831-1843. PubMed ID: 30733195
[TBL] [Abstract][Full Text] [Related]
3. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation.
Yao D; Dai C; Peng S
Mol Cancer Res; 2011 Dec; 9(12):1608-20. PubMed ID: 21840933
[TBL] [Abstract][Full Text] [Related]
6. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.
Chui MH
Int J Cancer; 2013 Apr; 132(7):1487-95. PubMed ID: 22833228
[TBL] [Abstract][Full Text] [Related]
7. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
8. Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.
Xu Y; Ma YH; Pang YX; Zhao Z; Lu JJ; Mao HL; Liu PS
Tumour Biol; 2017 May; 39(5):1010428317701627. PubMed ID: 28475014
[TBL] [Abstract][Full Text] [Related]
9. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.
Aokage K; Ishii G; Ohtaki Y; Yamaguchi Y; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Int J Cancer; 2011 Apr; 128(7):1585-95. PubMed ID: 20533280
[TBL] [Abstract][Full Text] [Related]
10. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.
Zhao M; Ang L; Huang J; Wang J
Tumour Biol; 2017 Feb; 39(2):1010428317691682. PubMed ID: 28222665
[TBL] [Abstract][Full Text] [Related]
13. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b.
Zhou W; Ye XL; Xu J; Cao MG; Fang ZY; Li LY; Guan GH; Liu Q; Qian YH; Xie D
Sci Signal; 2017 Jun; 10(483):. PubMed ID: 28611183
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck M; Christofori G
Curr Opin Cell Biol; 2016 Dec; 43():7-13. PubMed ID: 27371787
[TBL] [Abstract][Full Text] [Related]
16. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
Sommerova L; Ondrouskova E; Vojtesek B; Hrstka R
BMC Cancer; 2017 Aug; 17(1):546. PubMed ID: 28810836
[TBL] [Abstract][Full Text] [Related]
17. Autophagy is the key process in the re-establishment of the epitheloid phenotype during mesenchymal-epithelial transition (MET).
Zsiros V; Katz S; Dóczi N; Kiss AL
Exp Cell Res; 2017 Mar; 352(2):382-392. PubMed ID: 28228351
[TBL] [Abstract][Full Text] [Related]
18. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
Tyszka-Czochara M; Lasota M; Majka M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.
Palen K; Weber J; Dwinell MB; Johnson BD; Ramchandran R; Gershan JA
Oncotarget; 2016 Jul; 7(28):43363-43375. PubMed ID: 27270319
[TBL] [Abstract][Full Text] [Related]
20. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]